Literature DB >> 12404684

Serological observations in patients suffering from acute manic episodes.

Ahmed A Wadee1, Reverie H Kuschke, Lesley A Wood, Michael Berk, Liuvu Ichim, Michael Maes.   

Abstract

Although abnormalities of the immune system have been described in depression, information on serological alteration in acutely manic patients has been scarce. The present study undertook to investigate the levels of C-reactive proteins, circulating immune complexes, total immunoglobulins and immunoglobulin subclasses, complement proteins C3, C4, C6 and Factor B in the sera of 45 patients suffering from an acute manic episode. The findings were compared with assessments on the sera of 45 controls. The results demonstrate a number of significant differences between patients and controls. Whilst levels of immunoglobulin D were significantly lower, the levels of total immunoglobulin and immunoglobulin G1, complement proteins C3, C6 and Factor B were raised in the patient group when compared with the controls. Our results suggest a relationship between acute mania and immunological parameters associated with acute phase responses. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12404684     DOI: 10.1002/hup.390

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  28 in total

Review 1.  Stage managing bipolar disorder.

Authors:  Michael Berk; Lesley Berk; Seetal Dodd; Sue Cotton; Craig Macneil; Rothanthi Daglas; Philippe Conus; Andreas Bechdolf; Steven Moylan; Gin S Malhi
Journal:  Bipolar Disord       Date:  2013-06-20       Impact factor: 6.744

Review 2.  Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Authors:  Robert K McNamara; Francis E Lotrich
Journal:  Expert Rev Neurother       Date:  2012-09       Impact factor: 4.618

3.  Biomarkers and clinical staging in psychiatry.

Authors:  Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

Review 4.  Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites.

Authors:  George Anderson; Michael Maes
Journal:  Curr Psychiatry Rep       Date:  2015-02       Impact factor: 5.285

5.  Staging in bipolar disorder: from theoretical framework to clinical utility.

Authors:  Michael Berk; Robert Post; Aswin Ratheesh; Emma Gliddon; Ajeet Singh; Eduard Vieta; Andre F Carvalho; Melanie M Ashton; Lesley Berk; Susan M Cotton; Patrick D McGorry; Brisa S Fernandes; Lakshmi N Yatham; Seetal Dodd
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

Review 6.  Immune-based strategies for mood disorders: facts and challenges.

Authors:  Gabriela D Colpo; Marion Leboyer; Robert Dantzer; Mahdukar H Trivedi; Antonio L Teixeira
Journal:  Expert Rev Neurother       Date:  2017-11-27       Impact factor: 4.618

Review 7.  Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications.

Authors:  Nora Hamdani; Raphael Doukhan; Ozlem Kurtlucan; Ryad Tamouza; Marion Leboyer
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

8.  C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis.

Authors:  Jennifer K Melbourne; Cherise Rosen; Benjamin Feiner; Rajiv P Sharma
Journal:  Schizophr Res       Date:  2018-02-12       Impact factor: 4.939

9.  Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder.

Authors:  Angelo B Cunha; Ana C Andreazza; Fabiano A Gomes; Benicio N Frey; Leonardo E da Silveira; Carlos A Gonçalves; Flávio Kapczinski
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-02-23       Impact factor: 5.270

Review 10.  The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.

Authors:  Michael Maes; Raz Yirmyia; Jens Noraberg; Stefan Brene; Joe Hibbeln; Giulia Perini; Marta Kubera; Petr Bob; Bernard Lerer; Mario Maj
Journal:  Metab Brain Dis       Date:  2008-12-16       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.